Terms: = Prostate cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE
37 results:
1. The Role of Nucleases Cleaving TLR3, TLR7/8 and TLR9 Ligands, dicer RNase and miRNA/piRNA Proteins in Functional Adaptation to the Immune Escape and Xenophagy of prostate cancer Tissue.
Kocic G; Hadzi-Djokic J; Colic M; Veljkovic A; Tomovic K; Roumeliotis S; Smelcerovic A; Liakopoulos V
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613950
[TBL] [Abstract] [Full Text] [Related]
2. An autopsy case of prostatic rhabdomyosarcoma with dicer1 hotspot mutation.
Miyama Y; Makise N; Miyakawa J; Kume H; Fukayama M; Ushiku T
Pathol Int; 2021 Jan; 71(1):102-108. PubMed ID: 33112496
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of APC and PTEN Alterations in Urachal cancer.
Nagy N; Reis H; Hadaschik B; Niedworok C; Módos O; Szendrői A; Bíró K; Hager T; Herold T; Ablat J; Black PC; Okon K; Tolkach Y; Csizmarik A; Oláh C; Keresztes D; Bremmer F; Gaisa NT; Kriegsmann J; Kovalszky I; Kiss A; Tímár J; Szász MA; Rink M; Fisch M; Nyirády P; Szarvas T
Pathol Oncol Res; 2020 Oct; 26(4):2773-2781. PubMed ID: 32754865
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.
Liu X; Haniff HS; Childs-Disney JL; Shuster A; Aikawa H; Adibekian A; Disney MD
J Am Chem Soc; 2020 Apr; 142(15):6970-6982. PubMed ID: 32233464
[TBL] [Abstract] [Full Text] [Related]
5. Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer.
Verma S; Pandey M; Shukla GC; Singh V; Gupta S
PLoS One; 2019; 14(11):e0224071. PubMed ID: 31756185
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.
Khan S; Ayub H; Khan T; Wahid F
Biochimie; 2019 Dec; 167():12-24. PubMed ID: 31493469
[TBL] [Abstract] [Full Text] [Related]
7. MDA-7/IL-24 regulates the miRNA processing enzyme dicer through downregulation of MITF.
Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
[TBL] [Abstract] [Full Text] [Related]
8. Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.
Höti N; Shah P; Hu Y; Yang S; Zhang H
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28116790
[TBL] [Abstract] [Full Text] [Related]
9. microRNAs and dicer1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.
Dambal S; Giangreco AA; Acosta AM; Fairchild A; Richards Z; Deaton R; Wagner D; Vieth R; Gann PH; Kajdacsy-Balla A; Van der Kwast T; Nonn L
J Steroid Biochem Mol Biol; 2017 Mar; 167():192-202. PubMed ID: 28089917
[TBL] [Abstract] [Full Text] [Related]
10. Altered miRNA expression in high-fat diet-induced prostate cancer progression.
Nara T; Narita S; Mingguo H; Yoshioka T; Koizumi A; Numakura K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
Carcinogenesis; 2016 Dec; 37(12):1129-1137. PubMed ID: 27915273
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variants in RNA-induced silencing complex genes and prostate cancer.
Nikolić Z; Savić Pavićević D; Vučić N; Cerović S; Vukotić V; Brajušković G
World J Urol; 2017 Apr; 35(4):613-624. PubMed ID: 27498138
[TBL] [Abstract] [Full Text] [Related]
12. Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer.
Terzuoli E; Donnini S; Finetti F; Nesi G; Villari D; Hanaka H; Radmark O; Giachetti A; Ziche M
Oncotarget; 2016 Jul; 7(28):44350-44364. PubMed ID: 27322147
[TBL] [Abstract] [Full Text] [Related]
13. MiR-30a and miR-205 are downregulated in hypoxia and modulate radiosensitivity of prostate cancer cells by inhibiting autophagy via TP53INP1.
Xu CG; Yang MF; Fan JX; Wang W
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1501-8. PubMed ID: 27160121
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1.
Gu H; Liu M; Ding C; Wang X; Wang R; Wu X; Fan R
Cancer Med; 2016 Jun; 5(6):1174-82. PubMed ID: 26990493
[TBL] [Abstract] [Full Text] [Related]
15. The oncogenic roles of dicer1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract] [Full Text] [Related]
16. Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.
Fujii T; Shimada K; Tatsumi Y; Tanaka N; Fujimoto K; Konishi N
Mol Carcinog; 2016 Sep; 55(9):1378-86. PubMed ID: 26259043
[TBL] [Abstract] [Full Text] [Related]
17. Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells.
Liu TT; Arango-Argoty G; Li Z; Lin Y; Kim SW; Dueck A; Ozsolak F; Monaghan AP; Meister G; DeFranco DB; John B
RNA; 2015 Jun; 21(6):1159-72. PubMed ID: 25904138
[TBL] [Abstract] [Full Text] [Related]
18. Expression of dicer and its related miRNAs in the progression of prostate cancer.
Bian X; Shen Y; Zhang G; Gu C; Cai Y; Wang C; Zhu Y; Zhu Y; Zhang H; Dai B; Ye D
PLoS One; 2015; 10(3):e0120159. PubMed ID: 25768283
[TBL] [Abstract] [Full Text] [Related]
19. Down-regulation of dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.
Bian XJ; Zhang GM; Gu CY; Cai Y; Wang CF; Shen YJ; Zhu Y; Zhang HL; Dai B; Ye DW
Tumour Biol; 2014 Nov; 35(11):11571-8. PubMed ID: 25135428
[TBL] [Abstract] [Full Text] [Related]
20. Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers.
Fletcher CE; Dart DA; Bevan CL
Endocr Relat Cancer; 2014 Oct; 21(5):R409-29. PubMed ID: 25062737
[TBL] [Abstract] [Full Text] [Related]
[Next]
